Palo Alto, CA (PRWEB) September 25, 2013
The PAWS Pet Company, Inc. (OTCQB:PAWS), today announced that as part of its ongoing transition from the pet space to the pharmaceutical space, the Company has begun the process of changing its name to Praxsyn Corporation and will also change its state of incorporation from Illinois to Nevada.
The PAWS Pet Company, Inc. (OTCQB:PAWS), as part of its strategy to become a major player in the delivery of pharmaceutical products to consumers, has decided to change its name and state of incorporation. To that end, the name Praxsyn Corporation has been reserved with the Nevada Secretary of State and the Company has begun the work of complying with all relevant regulatory and supervisory agencies and organizations.
The Company also intends to unveil its new website, http://www.praxsyn.com, within the coming weeks.
In regards to our ongoing negotiations with Pharmacy Development, Inc. dba MESA Pharmacy (“MESA”), the parties are continuing their work towards finalizing an agreement in the timeliest manner possible; and in order to satisfy the regulatory requirement to furnish consolidated financial statements within seventy-five days of the closing of a material acquisition, the parties have decided to create a joint venture, with an intended acquisition after the completion of an audit of MESA’s financial statements.
About The PAWS Pet Company, Inc.
The PAWS Pet Company, Inc. is undergoing a transition from the pet space to the pharmaceutical space. This exciting transition strategy has been developed to take advantage of the changes underway in traditional medical services. PAWS believes that great opportunities exist in pharmaceuticals and how they are delivered to the public.
For more information on The PAWS Pet Company, go to http://www.thepawspetcompany.com.
For more information on Pharmacy Development Inc., go to http://www.pharmacydevelopment.com.
Company Contact: ir(at)thepawspetcompany(dot)com
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) and, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports we filed with the SEC.